Literature DB >> 7734108

Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system.

T Takahashi1, Y Deng, W Maruyama, P Dostert, M Kawai, M Naoi.   

Abstract

Uptake of catechol isoquinolines to dopamine cells was studied using human dopaminergic neuroblastoma SH-SY5Y cells. Only (R)-1,2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline [(R)-1,2-DiMeDHTIQ] was transported by dopamine uptake system, while (S)-1,2-DiMeDHTIQ, (R)- and (S)-1-methyl-6,7-dihydroxy-tetrahydroisoquinoline, and 1,2-dimethyl-6,7-dihydroxyisoquinolinum ion were not. Kinetical study showed that the uptake of (R)-1,2-DiMeDHTIQ followed the Michaelis-Menten equation, and the values of the Michaelis constant and the maximal velocity were obtained to be 102.6 +/- 36.9 microM and 66.0 +/- 2.8 pmol/min/mg protein. Dopamine was found to inhibit (R)-1,2-DiMeDHTIQ uptake competitively. These results suggest that the selective uptake by dopamine transporter may account for the specific neurotoxicity of (R)-1,2-DiMeDHTIQ to dopamine neurons.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7734108     DOI: 10.1007/bf01277014

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  24 in total

1.  Endogenous synthesis of N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of N-methylisoquinolinium ion, in the brains of primates with parkinsonism after systemic administration of 1,2,3,4-tetrahydroisoquinoline.

Authors:  T Niwa; H Yoshizumi; A Tatematsu; S Matsuura; M Yoshida; M Kawachi; M Naoi; T Nagatsu
Journal:  J Chromatogr       Date:  1990-11-30

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Rat brain salsolinol and blood-brain barrier.

Authors:  T Origitano; J Hannigan; M A Collins
Journal:  Brain Res       Date:  1981-11-16       Impact factor: 3.252

4.  N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.

Authors:  W Maruyama; D Nakahara; M Ota; T Takahashi; A Takahashi; T Nagatsu; M Naoi
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

5.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

Authors:  K Chiba; A Trevor; N Castagnoli
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

6.  Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry.

Authors:  T Niwa; W Maruyama; D Nakahara; N Takeda; H Yoshizumi; A Tatematsu; A Takahashi; P Dostert; M Naoi; T Nagatsu
Journal:  J Chromatogr       Date:  1992-07-01

7.  Selective release of serotonin by endogenous alkaloids, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, (R)- and (S)salsolinol, in the rat striatum; in vivo microdialysis study.

Authors:  W Maruyama; D Nakahara; P Dostert; H Hashiguchi; S Ohta; M Hirobe; A Takahashi; T Nagatsu; M Naoi
Journal:  Neurosci Lett       Date:  1993-01-12       Impact factor: 3.046

8.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

Authors:  J A Javitch; R J D'Amato; S M Strittmatter; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

9.  An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.

Authors:  T Nagatsu; M Yoshida
Journal:  Neurosci Lett       Date:  1988-04-22       Impact factor: 3.046

10.  A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion.

Authors:  M Naoi; S Matsuura; T Takahashi; T Nagatsu
Journal:  Biochem Biophys Res Commun       Date:  1989-06-30       Impact factor: 3.575

View more
  14 in total

1.  Sphingosine kinase 1 and sphingosine-1-phosphate in oxidative stress evoked by 1-methyl-4-phenylpyridinium (MPP+) in human dopaminergic neuronal cells.

Authors:  Joanna Pyszko; Joanna B Strosznajder
Journal:  Mol Neurobiol       Date:  2014-01-09       Impact factor: 5.590

2.  Pinocembrin protects SH-SY5Y cells against MPP+-induced neurotoxicity through the mitochondrial apoptotic pathway.

Authors:  Yumin Wang; Junhong Gao; Yingchun Miao; Qifu Cui; Weili Zhao; Junyi Zhang; Hongquan Wang
Journal:  J Mol Neurosci       Date:  2014-01-07       Impact factor: 3.444

3.  PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment.

Authors:  Eun-Joo Shin; Chu Xuan Duong; Xuan-Khanh Thi Nguyen; Guoying Bing; Jae-Hyung Bach; Dae Hun Park; Keiichi Nakayama; Syed F Ali; Anumantha G Kanthasamy; Jean L Cadet; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2011-06-13       Impact factor: 3.921

Review 4.  Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

Authors:  M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

5.  Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid.

Authors:  W Maruyama; H Narabayashi; P Dostert; M Naoi
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway.

Authors:  Chi Xin Tiong; Ming Lu; Jin-Song Bian
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

7.  Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells.

Authors:  T Takahashi; W Maruyama; Y Deng; P Dostert; D Nakahara; T Niwa; S Ohta; M Naoi
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

8.  Insights into the Pharmacokinetics and In Vitro Cell-Based Studies of the Imidazoline I2 Receptor Ligand B06.

Authors:  Andrea Bagán; José A Morales-García; Christian Griñán-Ferré; Caridad Díaz; José Pérez Del Palacio; Maria C Ramos; Francisca Vicente; Belén Pérez; José Brea; María Isabel Loza; Mercè Pallàs; Carmen Escolano
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

9.  Activation of Wnt/β-catenin pathway by exogenous Wnt1 protects SH-SY5Y cells against 6-hydroxydopamine toxicity.

Authors:  Lei Wei; Congcong Sun; Ming Lei; Guofei Li; Li Yi; Feifei Luo; Yi Li; Li Ding; Zhuolin Liu; Shaomin Li; Pingyi Xu
Journal:  J Mol Neurosci       Date:  2012-10-11       Impact factor: 3.444

10.  Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease.

Authors:  Jose A Morales-Garcia; Miriam Redondo; Sandra Alonso-Gil; Carmen Gil; Concepción Perez; Ana Martinez; Angel Santos; Ana Perez-Castillo
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.